OSSIO has developed OSSIOfiber, which enables intelligent bone regeneration.
OSSIO’s patented OSSIOfiber is based on a biocomposite material utilizing intelligent bone regeneration.
OSSIOfiber is made of mineral blend reinforcing mineral fibers and has been clinically proven in several commercially available synthetic bone filler products, enabling patients to regenerate tissues and bones and recover from orthopedic disorders.
INDUSTRY
MILESTONES
Founded: 2014
Arc investment: 2019
FDA approval: 2019
First surgical use: April 2020